Both receptors influence glucose metabolism
Your medical history, pregnancies, future family plans, and weight stability are all considered
What's the difference between Ozempic, Wegovy, and Rybelsus for treating diabetes and obesity
Based on current trial populations and how the FDA has handled semaglutide and tirzepatide approvals, expected eligibility criteria are: BMI 30 , or BMI 27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, OSA) Adults 18 and older Not pregnant or breastfeeding No history of MTC or MEN 2 Retatrutide will almost certainly launch at a high price point estimates suggest $1,200$1,500 per month at list price
When combined with proper medical guidance, CJC-1295 offers longer lasting support, making it more suitable for long term wellness goals